Literature DB >> 18823851

Declining length of hospital stay for pneumonia and postdischarge outcomes.

Alberto Capelastegui1, Pedro P España, José M Quintana, Maitane Gallarreta, Inmaculada Gorordo, Cristobal Esteban, Isabel Urrutia, Amaia Bilbao.   

Abstract

OBJECTIVE: This study was designed to assess 8-year trends in the duration of hospitalization for community-acquired pneumonia and to evaluate the impact of declining length of stay on postdischarge short-term readmission and mortality.
METHODS: We conducted a prospective observational cohort study of 1886 patients with community-acquired pneumonia who were discharged from a single hospital between March 1, 2000, and June 30, 2007. The main outcomes measured were all-cause mortality and hospital readmission during the 30-day period after discharge. Regression models were used to identify risk factors associated with hospital length of stay and the adjusted associations between length of stay and mortality and readmission.
RESULTS: Factors associated with a longer hospital stay included the number of comorbid conditions, high risk classification on the Pneumonia Severity Index, bilateral or multilobe radiographic involvement, and treatment failure. Patients treated with an appropriate antibiotic were less likely to have an increased length of stay. The mean length of stay was significantly shorter during the 2006 to 2007 period (3.6 days) than during the 2000 to 2001 period (5.6 days, P<.001). Despite the reduction in length of stay, there were no significant differences in the likelihood of death or readmission at 30 days between the 2 time periods. Adjusted multivariate analysis showed that patients with hospital stays less than 3 days did not have significant increases in postdischarge outcomes.
CONCLUSION: The marked decreased in the length of stay for patients hospitalized with community-acquired pneumonia since 2000 has not been accompanied by an increase in short-term mortality or hospital readmission.

Entities:  

Mesh:

Year:  2008        PMID: 18823851     DOI: 10.1016/j.amjmed.2008.05.010

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Hospital Readmission Rates in U.S. States: Are Readmissions Higher Where More Patients with Multiple Chronic Conditions Cluster?

Authors:  Jayasree Basu; Rosa Avila; Richard Ricciardi
Journal:  Health Serv Res       Date:  2015-10-20       Impact factor: 3.402

3.  Risk factors for hospital readmissions in pneumonia patients: A systematic review and meta-analysis.

Authors:  Yuan-Yuan Fang; Jian-Chao Ni; Yin Wang; Jian-Hong Yu; Ling-Ling Fu
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

4.  Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI Choosing Wisely Campaign.

Authors:  Ludovico Furlan; Luca Erba; Lucia Trombetta; Roberto Sacco; Giorgio Colombo; Giovanni Casazza; Monica Solbiati; Nicola Montano; Chiara Marta; Rodolfo Sbrojavacca; Francesco Perticone; Gino Roberto Corazza; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2018-10-08       Impact factor: 3.397

5.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

6.  Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Authors:  Isabelle Suter-Widmer; Mirjam Christ-Crain; Werner Zimmerli; Werner Albrich; Beat Mueller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2012-05-20       Impact factor: 3.317

7.  Antibiotic expected effectiveness and cost under real life microbiology: evaluation of ertapenem and ceftriaxone in the treatment of community-acquired pneumonia for elderly patients in Spain.

Authors:  Santiago Grau; Virginia Lozano; Amparo Valladares; Rafael Cavanillas; Yang Xie; Gonzalo Nocea
Journal:  Clinicoecon Outcomes Res       Date:  2014-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.